National Vaccine Information Center Your Health. Your Family. Your Choice.

MedAlerts Home

Administered by: Unknown      Purchased by: Unknown
Symptoms: Epistaxis, Petechiae, Platelet count decreased, Thrombocytopenic purpura

Life Threatening? Yes
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Synthroid, Claritin, Fosamax
Current Illness: None
Preexisting Conditions: Hypothyroidism, osteopenia, allergic rhinitis, No known drug allergies.
Diagnostic Lab Data: Platelet count 3,000 on 17 June 2006. Platelet count 160,000 on 21 June 2006 after IVIG and steroid treatment.
CDC 'Split Type':

Write-up:Nosebleed on morning of 17 June 2006; petechiae developed on evening of 17 June 2006, so patient went to ER; Idiopathic Thrombocytopenic Purpura was diagnosed. She was admitted and treated with platelet transfusion, IVIG, and IV corticosteroids.

Changed on 12/8/2009

Administered by: Unknown      Purchased by: Unknown
Symptoms: Epistaxis, Petechiae, Platelet count decreased, Thrombocytopenic purpura

Life Threatening? Yes
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Synthroid, Claritin, Fosamax
Current Illness: None
Preexisting Conditions: Hypothyroidism, osteopenia, allergic rhinitis, No known drug allergies. allergies.PMH:
Diagnostic Lab Data: Platelet count 3,000 on 17 June 2006. Platelet count 160,000 on 21 June 2006 after IVIG and steroid treatment. Labs on admission: WBC 4.9, platelets day 2 at 21,000. 10% reactive lymphocytes and increase from 7% on day of admission. UA mo
CDC 'Split Type':

Write-up:Nosebleed on morning of 17 June 2006; petechiae developed on evening of 17 June 2006, so patient went to ER; Idiopathic Thrombocytopenic Purpura was diagnosed. She was admitted and treated with platelet transfusion, IVIG, and IV corticosteroids. 7/18/06-Presented to ED with petechial rash. Plt on admission 3000. Admitting DX thrombocytopenia. PMH: hypothyroidism and osteopenia. Recently visited China. Received 1st dose of encephalitis vaccine on 6/6/06 and 2nd dose 6/12/06 with 3rd dose scheduled week of 6/25/06. Hematology and Infectious Disease consults requested. PSH: Status post repair of deviated septum in 1994 with hemorrhage status post right 5th to hammer toe repair. Skin biopsy 1 week prior to this admission no firm diagnosis with possible diagnosis of lichen sclerosis. Current Meds: Fosamax and Synthroid. PE normal with petechia on the oral mucosa and 2 sits of what appear to have been blood blisters the overlying mucosa of which is torn. 7/26/06-a DC summary is not dictated for a stay of 48 hours or <. Med Rec will fax DC face sheet that includes DC DX. 8/1/06-DC DX received from hospital: Principal DX: Other and unspecified complication of medical care. Secondary DX: immune thrombocytopenic purpura and unspecified acquired hypothyroidism.

Changed on 6/13/2012

Administered by: Unknown Military      Purchased by: Unknown Military
Symptoms: Epistaxis, Petechiae, Platelet count decreased, Thrombocytopenic purpura

Life Threatening? Yes
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Synthroid, Claritin, Fosamax
Current Illness: None
Preexisting Conditions: Hypothyroidism, osteopenia, allergic rhinitis, No known drug allergies.PMH: allergies. PMH:
Diagnostic Lab Data: Platelet count 3,000 on 17 June 2006. Platelet count 160,000 on 21 June 2006 after IVIG and steroid treatment. Labs on admission: WBC 4.9, platelets day 2 at 21,000. 10% reactive lymphocytes and increase from 7% on day of admission. UA mo moderate blood.
CDC 'Split Type':

Write-up:Nosebleed on morning of 17 June 2006; petechiae developed on evening of 17 June 2006, so patient went to ER; Idiopathic Thrombocytopenic Purpura was diagnosed. She was admitted and treated with platelet transfusion, IVIG, and IV corticosteroids. 7/18/06-Presented to ED with petechial rash. Plt on admission 3000. Admitting DX thrombocytopenia. PMH: hypothyroidism and osteopenia. Recently visited China. foreign country. Received 1st dose of encephalitis vaccine on 6/6/06 and 2nd dose 6/12/06 with 3rd dose scheduled week of 6/25/06. Hematology and Infectious Disease consults requested. PSH: Status post repair of deviated septum in 1994 with hemorrhage status post right 5th to hammer toe repair. Skin biopsy 1 week prior to this admission no firm diagnosis with possible diagnosis of lichen sclerosis. Current Meds: Fosamax and Synthroid. PE normal with petechia on the oral mucosa and 2 sits of what appear to have been blood blisters the overlying mucosa of which is torn. 7/26/06-a DC summary is not dictated for a stay of 48 hours or <. Med Rec will fax DC face sheet that includes DC DX. 8/1/06-DC DX received from hospital: Principal DX: Other and unspecified complication of medical care. Secondary DX: immune thrombocytopenic purpura and unspecified acquired hypothyroidism.

Changed on 6/14/2014

Administered by: Military      Purchased by: Military
Symptoms: Epistaxis, Petechiae, Platelet count decreased, Thrombocytopenic purpura

Life Threatening? Yes
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Synthroid, Claritin, Fosamax
Current Illness: None
Preexisting Conditions: Hypothyroidism, osteopenia, allergic rhinitis, No known drug allergies. PMH:
Diagnostic Lab Data: Platelet count 3,000 on 17 June 2006. Platelet count 160,000 on 21 June 2006 after IVIG and steroid treatment. Labs on admission: WBC 4.9, platelets day 2 at 21,000. 10% reactive lymphocytes and increase from 7% on day of admission. UA moderate blood.
CDC 'Split Type':

Write-up:Nosebleed on morning of 17 June 2006; petechiae developed on evening of 17 June 2006, so patient went to ER; Idiopathic Thrombocytopenic Purpura was diagnosed. She was admitted and treated with platelet transfusion, IVIG, and IV corticosteroids. 7/18/06-Presented to ED with petechial rash. Plt on admission 3000. Admitting DX thrombocytopenia. PMH: hypothyroidism and osteopenia. Recently visited foreign country. Received 1st dose of encephalitis vaccine on 6/6/06 and 2nd dose 6/12/06 with 3rd dose scheduled week of 6/25/06. Hematology and Infectious Disease consults requested. PSH: Status post repair of deviated septum in 1994 with hemorrhage status post right 5th to hammer toe repair. Skin biopsy 1 week prior to this admission no firm diagnosis with possible diagnosis of lichen sclerosis. Current Meds: Fosamax and Synthroid. PE normal with petechia on the oral mucosa and 2 sits of what appear to have been blood blisters the overlying mucosa of which is torn. 7/26/06-a DC summary is not dictated for a stay of 48 hours or <. Med Rec will fax DC face sheet that includes DC DX. 8/1/06-DC DX received from hospital: Principal DX: Other and unspecified complication of medical care. Secondary DX: immune thrombocytopenic purpura and unspecified acquired hypothyroidism.

Changed on 5/14/2017

Administered by: Military      Purchased by: Military
Symptoms: Epistaxis, Petechiae, Platelet count decreased, Thrombocytopenic purpura

Life Threatening? Yes
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Synthroid, Claritin, Fosamax
Current Illness: None
Preexisting Conditions: Hypothyroidism, osteopenia, allergic rhinitis, No known drug allergies. PMH:
Diagnostic Lab Data: Platelet count 3,000 on 17 June 2006. Platelet count 160,000 on 21 June 2006 after IVIG and steroid treatment. Labs on admission: WBC 4.9, platelets day 2 at 21,000. 10% reactive lymphocytes and increase from 7% on day of admission. UA moderate blood.
CDC 'Split Type':

Write-up:Nosebleed on morning of 17 June 2006; petechiae developed on evening of 17 June 2006, so patient went to ER; Idiopathic Thrombocytopenic Purpura was diagnosed. She was admitted and treated with platelet transfusion, IVIG, and IV corticosteroids. 7/18/06-Presented to ED with petechial rash. Plt on admission 3000. Admitting DX thrombocytopenia. PMH: hypothyroidism and osteopenia. Recently visited foreign country. Received 1st dose of encephalitis vaccine on 6/6/06 and 2nd dose 6/12/06 with 3rd dose scheduled week of 6/25/06. Hematology and Infectious Disease consults requested. PSH: Status post repair of deviated septum in 1994 with hemorrhage status post right 5th to hammer toe repair. Skin biopsy 1 week prior to this admission no firm diagnosis with possible diagnosis of lichen sclerosis. Current Meds: Fosamax and Synthroid. PE normal with petechia on the oral mucosa and 2 sits of what appear to have been blood blisters the overlying mucosa of which is torn. 7/26/06-a DC summary is not dictated for a stay of 48 hours or <. Med Rec will fax DC face sheet that includes DC DX. 8/1/06-DC DX received from hospital: Principal DX: Other and unspecified complication of medical care. Secondary DX: immune thrombocytopenic purpura and unspecified acquired hypothyroidism.

New Search